Biotech News 24 August 2025

Regencell (RGC) Stock Skyrockets 64,000% – Miracle Biotech or Bubble?

RGC’s 2025 Rollercoaster: From Penny Stock to $33B Phenomenon Regencell Bioscience’s journey in 2025 has been nothing short of astonishing. The company went from an obscure penny stock (literally trading under 10 cents) to a meteoric high of $83.60 within

4 October 2025

Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside

Mesoblast’s stock has surged recently on the Ryoncil news. At the Oct 2 close it stood at $17.02 – up +4.6% on the day and roughly +8% from two weeks prior stockinvest.us marketbeat.com. This rally follows last week’s announcements: on

3 October 2025

Analyst Ratings · Biotech · Investing · Market News · NASDAQ:MSB · Stock Market · Stocks

Sarepta Therapeutics (SRPT) Surges After FDA Greenlights Duchenne Gene Therapy – Is a Rebound Ahead?

Stock Performance and Trends Sarepta’s stock is recovering some ground after steep losses. As of Oct 2, 2025, SRPT closed at $19.57, up about 6.8%for the day investing.com. This followed a general uptrend in recent weeks: SRPT is up roughly 16% over the last

2 October 2025

Biotech · FDA Approvals · Gene Therapy · NASDAQ:SRPT · Pharmaceuticals · Stock Analysis · Stock Market

Crinetics (CRNX) Stock Skyrockets on FDA Approval – Full 2025 Investor Update

Stock Price Performance (YTD & Recent) Crinetics stock has been volatile but trending upward in 2025, with the recent FDA catalyst propelling it sharply higher. On September 26, 2025, CRNX closed around $45–$46, up roughly +28% in a single day

26 September 2025

Biotech · FDA Approval · Investors · NASDAQ:CRNX · Pharmaceuticals · Stock Market · Stocks

Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara Therapeutics (CDTX) Stock and Company Update as of September 24, 2025 Stock Performance & Technical Analysis Cidara’s stock has been on a tear in 2025, delivering triple-digit percentage gains. Year-to-date, CDTX has risen about +173% as of late September investing.com, driven by

24 September 2025

Biotech · Drug Development · Investor Updates · NASDAQ:CDTX · Pharma News · Stock Market

Engineered Living Therapeutics: How “Bugs as Drugs” Are Transforming Medicine in 2025

Introduction: Living Cells as Medicine Imagine treating disease by swallowing a pill full of programmed bacteria that take up residence in your gut and produce medicines from within. This sci-fi concept is rapidly becoming reality. Engineered Living Therapeutics (ELTs) refer

10 September 2025

Biotech · Drug Innovation · Living Therapeutics · Medicine 2025 · Microbes

Alzheimer’s At-Home Shot Approved, Bird Flu Scare, and CDC Shake-Up – Global Biotech & Health Roundup (Aug 29–30, 2025)

Key Facts Scientific Breakthroughs & New Research Leading our roundup are several significant scientific and medical breakthroughs. Researchers in New York unveiled a potential “universal” antiviral strategy, reporting compounds that neutralized seven different viruses across multiple families in lab tests

30 August 2025

Biotech · Global News · Health · Medicine · NASDAQ:CYTK · NYSE:GSK · NYSE:SNY · Public Health

Obesity Pill Breakthrough, Gene Therapy Triumph & Billion-Dollar Psychedelic Bet – Global Biotech & Health Highlights (Aug 26–27, 2025)

Key Facts Sources

27 August 2025

Biotech · Gene Therapy · Health · NASDAQ:PGEN · NYSE:ABBV · NYSE:LLY · Obesity · Psychedelics

Billion-Dollar Pharma Deals, Biotech Breakthroughs & Global Health Alerts – Biotech & Health News Roundup (Aug 25–26, 2025)

Biotech & Pharma Industry Updates Regulatory & Drug Approvals Clinical Trials & Innovations Medical Research Highlights Health Policy & Government Public Health & Global Health Alerts Sources: This report draws on recent press releases and expert commentary from Reuters, AP,

26 August 2025

Biotech · Global Alerts · Health · NYSE:ABBV · Pharma · Science News

AI Storm: $10B Cloud Deals, Biotech Breakthroughs & Backlash (Aug 25–26, 2025 AI News Roundup)

Meta inked a six-year cloud deal worth over $10 billion with Google to power its AI push, as Meta raised its 2025 capital expenditure forecast to $66–72 billion and moved to offload $2 billion in data-center assets. Nvidia unveiled a

26 August 2025

AI News · Biotech · Cloud Computing · Market Trends · NASDAQ:GOOGL · NASDAQ:META · NASDAQ:NVDA · NYSE:IBM · Tech Industry

FDA Shockers, Breakthrough Trials & Outbreak Alerts – Biotech & Health News Roundup (Aug 24–25, 2025)

Regulatory Announcements: Approvals & Rejections Clinical Trial Breakthroughs & Research Highlights Industry Deals, Mergers & Investments Public Health Policy & Governance Updates Emerging Diseases & Vaccine News This comprehensive roundup highlights the fast-moving developments in biotech, pharma, and health over

25 August 2025

Biotech · FDA · Health · Medical Trials · Outbreaks

Breakthrough Cures, Billion-Dollar Bets & Health Shockers – Global Biotech & Health News Roundup (Aug 23–24, 2025)

Regulatory Approvals & Clinical Milestones Pharma & Biotech Industry Moves Startups & Innovation Highlights ([…Placeholder – if needed, otherwise this section can be omitted due to a lack of specific startup news on Aug 23–24 beyond the AI deal covered

24 August 2025

Biotech · Global Health · Healthcare · Investments · Medical Breakthroughs · NASDAQ:DVAX · NASDAQ:RCKT · NYSE:GSK · NYSE:NVO

Biotech News 24 August 2025 - 4 October 2025